## Summary

This paper proposes an end-to-end framework for multi-view diabetic retinopathy (DR) grading that generates lesion-aware cues internally rather than relying on costly external pixel-level annotations. The framework combines two modules: GALP, which extracts grade-conditioned evidence maps from auxiliary classifiers and selects top-K regions as "lesion proposals"; and LGRF, which uses a gated mixture-of-experts and cross-view attention to fuse these proposals across views. Results on two datasets (MFIDDR, DRTiD) show the lesion-free variant (83.9% Acc on MFIDDR) surpasses all end-to-end baselines and matches several externally-informed methods.

## Strengths

- **Strong quantitative results on both datasets.** On MFIDDR (Table 1), the w/o-lesion variant (83.9% Acc, 70.9 Kappa) surpasses every end-to-end baseline (next best: ETMC at 81.5% Acc, 64.8 Kappa) and matches/exceeds several externally-informed methods. On DRTiD (Table 3), the method achieves the best overall accuracy (76.0%) against all baselines including CrossFIT (75.6%). These are not marginal differences against end-to-end methods.

- **Well-motivated problem with a clear framing.** The paper articulates a genuine practical bottleneck — the reliance on costly pixel-level lesion/vessel annotations and the brittleness of external supervision pipelines — and the three-stage narrative (single-view → multi-view → end-to-end limitations) effectively motivates why self-derived proposals would be valuable.

- **Clean ablation study confirming modular contributions.** Table 4 shows that removing each component (GALP, Experts, LGRF) produces measurable accuracy drops (82.7 → 82.6 → 82.3 vs. full 83.9), confirming that both modules and the expert pool contribute additively.

- **Useful hyperparameter analysis.** Figure 3 provides meaningful sensitivity information for retention ratio α, number of routed experts K₂, and total experts M, with clear optima (α=0.5, K₂=2, M=6).

## Weaknesses

### Major

- **The central claim that GALP generates "lesion proposals" is never validated.** This is the paper's main thesis — that top-K patches from grade-conditioned evidence maps act as surrogates for expert lesion annotations. However, no evidence is provided that these proposals actually correspond to lesions. CAMs highlight whatever is most discriminative for the grade classifier, which could include lesions but equally could pick up on image-level artifacts (illumination differences correlated with disease severity, field-of-view cropping patterns, view-specific framing biases). The MFIDDR dataset *has* lesion segmentation masks available from its provider (stated in Section 4.1), yet the paper presents no qualitative analysis (e.g., proposal overlays on fundus images), no overlap metrics (IoU/Dice with ground-truth lesion masks), and no interpretability analysis of any kind — despite claiming "interpretability" as a contribution (line 44). The method's empirical results are valid, but the narrative about lesion-grounded proposals and the associated interpretability claim are unsubstantiated.

- **No variance or statistical significance is reported for any result.** All Tables (1–4) present single point estimates from one train/test split. Several margins over strong baselines are small: on MFIDDR, 83.9% vs. SMVDR-M's 84.0% (a 0.1% gap *against* the method on an externally-informed baseline); on DRTiD, 76.0% vs. CrossFIT's 75.6% (0.4% gap). Without variance estimates across multiple runs, the reliability of these claimed improvements cannot be assessed, especially given stochastic components in the method (expert routing, Top-K selection).

- **The "Ours (with lesion)" variant introduces external annotations via a different architectural mechanism (SPADE input-level conditioning), not through the GALP/LGRF pipeline.** This comparison does not isolate the effect of adding external cues to the proposed modules — it evaluates the proposed framework *plus a separate input-level mechanism*. The claim that "when external information is available, our framework can incorporate it and attain state-of-the-art results" conflates stacking an unrelated mechanism with integration into the proposed design.

- **The ablation study does not isolate whether GALP's benefit comes from the proposal selection mechanism versus the auxiliary classification loss alone.** The "w/o GALP" ablation removes both the auxiliary loss *and* the proposal-based filtering. An ablation that *keeps the auxiliary loss* but uses random token selection (or all tokens) would determine whether the proposal *selection* specifically adds value beyond the extra gradient signals from the auxiliary classifiers. The observed 1.2% drop (83.9→82.7) could be entirely due to removing the auxiliary supervision, not the proposal mechanism.

### Minor

- **No simple vanilla backbone baseline is included.** The ablations ("w/o GALP", "w/o LGRF") are still more complex than a plain multi-view Swin-B classifier. Establishing a true baseline (Swin-B with no auxiliary losses, no proposals, no MoE) would clarify what each module adds.

- **No discussion of computational cost.** The method adds auxiliary classifiers at three stages, MoE with 6 experts, and cross-view attention. Training/inference time and parameter counts relative to baselines are not reported, which is relevant for practical deployment.

- **Backbone asymmetry in comparisons.** The method uses Swin-B, while several baselines use different architectures (MVCINN uses hybrid CNN-attention, MVCNN uses ResNet/VGG). The paper does not discuss whether some improvements may partly reflect the backbone choice rather than the proposed modules.

- **No discussion of failure cases or limitations** for this clinical application.

### Trivial

None.

## Nice-to-Haves

- An ablation that keeps the auxiliary losses but replaces CAM-based token selection with random selection (or all tokens) to isolate the proposal mechanism's contribution.
- Qualitative examples of GEMs/proposals overlaid on fundus images, ideally with IoU/Dice against the available MFIDDR lesion segmentation masks.
- Reporting results across multiple runs with means and standard deviations.
- Clarify which CAM variant is used (LayerCAM vs. standard CAM on GAP weights).

## Removed Points

These points from the harsh critic review were filtered out:
- **"Equation (3) notation inconsistency"** — minor notational point about a superscript; does not affect correctness or reproducibility.
- **"LayerCAM vs. standard CAM citation question"** — clarification request, not a substantive weakness.
- **"LGRF routing: current-view features gating adjacent-view experts doesn't measure cross-view agreement"** — this is a design choice, not an error; the proposed alternative would not change the core contribution.
- **"Load balancing loss formulation needs clarification"** — the reviewer acknowledges the formulation "looks correct in structure."
- **"DRTiD pretrained on EyePACS vs. ImageNet for MFIDDR"** — the paper explicitly acknowledges this follows prior work; it is a reasonable experimental choice, not a flaw.
- **"Robustness claim not measured"** — the term is used loosely in the contributions line; the core issue (unvalidated proposals) already covers the interpretation concern.
- **"w/o LGRF ablation underspecified"** — the description is sufficient for the ablation's purpose, though more detail would be welcome.

## Novel Insights

None beyond the paper's own contributions. The reviewer analysis correctly identifies that the central narrative — linking CAM-derived proposals to actual lesions — lacks direct empirical support, and that the current experiments conflate the proposal selection mechanism with the auxiliary supervision that enables it.

## Suggestions

1. **Validate the lesion-proposal correspondence.** Use the MFIDDR lesion segmentation masks (already available) to compute IoU/Dice between proposal regions and ground-truth lesions, or at minimum show qualitative overlays of GEMs/proposals on fundus images. This is critical for the paper's central narrative.
2. **Add an ablation that isolates the proposal selection from the auxiliary loss.** Keep the auxiliary classifiers but replace CAM-based token selection with random selection to test whether the *proposal mechanism* adds value beyond supervision.
3. **Report means and standard deviations across multiple runs** (at least 3–5) for all main results and ablations.
4. **Include a simple Swin-B multi-view baseline** (no auxiliary losses, no GALP, no LGRF) to establish the true starting point.
5. **Clarify the "with lesion" variant's relationship to the proposed framework.** Since SPADE is a separate input-level mechanism, either reframe the comparison or add an experiment that feeds ground-truth proposals into the GALP/LGRF pipeline directly.

## Score and Decision

**Calibration Summary.** Three rounds of calibration retrieval across ~20 anchors. Closest topical anchors: M4oE (multi-modal medical MoE, avg 5.75, accepted) which also lacked confidence intervals and had ablation granularity concerns; TEF (trusted multi-view classification, avg 6.25, accepted) with a strong empirical evaluation; Scale-Aware Contrastive Reverse Distillation (medical anomaly detection, avg 6.50, accepted) with similar weakness negativity levels (~ -1.7 to -3.5 vs. -2.6 for this paper). The DynaMer Adapter (medical MoE, avg 4.75, rejected) had more severe weaknesses: marginal improvements, unclear novelty (weakness favorability -3.66).

**Placement.** The reviewed paper's quantitative results are genuinely strong (strength favorability 14.79, exceeding the 14.28 top-strength of the 6.50 anchor). However, its most negative weaknesses (favorability -2.35 and -2.60) reflect an unvalidated central claim and absent variance reporting — more foundational than the "incremental novelty" concerns in the 6.50 anchor (-1.70). The ablation gap (favorability 2.59) is less severe than the most negative weaknesses in the 4.75 anchor (-3.66). Round-1 bracket was [3.5, 7.5]; round 2 narrowed to [5.5, 6.5] after comparing against M4oE (5.75) and the 6.50 anchor, which had similar weakness profiles but less central narrative risk.

**Final score: 6.0.** The paper presents a novel and empirically effective approach with genuine contributions. However, the core narrative about lesion-grounded proposals remains unvalidated, and the absence of variance reporting undermines confidence in the claimed margins. The method's technical contribution (CAM-based discriminative region selection + MoE-guided cross-view fusion) is sound; the interpretive leap to "lesion proposals" and the claimed interpretability are what need strengthening.

MY FINAL SCORE: <score>6.0</score>
MY FINAL DECISION: <decision>Accept</decision>